{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:12:59Z","timestamp":1788250379663,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GALAXYOB18"],"award-info":[{"award-number":["GALAXYOB18"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SATHE19KO"],"award-info":[{"award-number":["SATHE19KO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015977","name":"Center for Research in Security Prices","doi-asserted-by":"publisher","award":["\\u2013 SATHE18Y0-5"],"award-info":[{"award-number":["\\u2013 SATHE18Y0-5"]}],"id":[{"id":"10.13039\/100015977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T20:59:18Z","timestamp":1721768358000},"page":"991-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-506X","authenticated-orcid":false,"given":"MinJae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-8530","authenticated-orcid":false,"given":"Meghana","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha","family":"Moshiree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong T.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Jane","family":"Schwarzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jay","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2024.07.013_bib0001","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmjebm-2020-111573","article-title":"Patient-reported outcome measures (PROMs) as proof of treatment efficacy","volume":"27","author":"Kluzek","year":"2022","journal-title":"BMJ Evid Based Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.013_bib0002","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2020.12.021","article-title":"Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms","volume":"20","author":"Freeman","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.07.013_bib0003","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.013_bib0004","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11136-004-9567-x","article-title":"Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders","volume":"13","author":"Rentz","year":"2004","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.013_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/00365520510012208","article-title":"Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire","volume":"40","author":"Marquis","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2024.07.013_bib0006","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.14349","article-title":"The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference","volume":"46","author":"Yiannakou","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2024.07.013_bib0008","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cgh.2021.05.004","article-title":"Establishing Minimal Clinically Important Difference in Quality of Life Measures in Opioid Induced Constipation","volume":"20","author":"Tack","year":"2022","journal-title":"Clinical Gastro and Hep"},{"key":"10.1016\/j.jcf.2024.07.013_bib0010","series-title":"Psychological testing","author":"Anastasi","year":"1997"},{"key":"10.1016\/j.jcf.2024.07.013_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jclinepi.2007.06.008","article-title":"Qualiveen, a Urinary-Disorder Specific Instrument: 0.5 Corresponds to the Minimal Important Difference","volume":"61","author":"Bonniaud","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.013_bib0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","article-title":"PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","volume":"20","author":"Nichols","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.013_bib0012","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcf.2021.07.002","article-title":"Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study","volume":"20","author":"Sathe","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.013_bib0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcf.2022.10.006","article-title":"Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis","volume":"22","author":"Moshiree","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2024.07.013_bib0014","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.013_bib0009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/nmo.12738","article-title":"Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations","volume":"28","author":"Chumpitazi","year":"2016","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.013_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1016\/j.jcf.2024.07.013_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00005650-199905000-00006","article-title":"Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life","volume":"37","author":"Wyrwich","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.jcf.2024.07.013_bib0017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2024.07.013_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002281-200203000-00006","article-title":"Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research","volume":"14","author":"Beaton","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jcf.2024.07.013_bib0019","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A Combination of Distribution-and Anchor Based Approaches Determined Minimally Important Differences (MIDs) for Four Endpoints in a Breast Cancer Scale","volume":"57","author":"Eton","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2024.07.013_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.jcf.2024.07.013_bib0007","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1542-3565(04)00348-9","article-title":"Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders","volume":"2","author":"Revicki","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.013_bib0023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Promise Study Group. Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2023","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324007987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324007987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:05Z","timestamp":1788246845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324007987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1569199324007987"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}